Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CNCE ROE (Return on Equity)

The ROE (Return on Equity) of Concert Pharmaceuticals Inc (CNCE) is -71.33%.

ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.

CNCE ROE (Return on Equity) - Historical Value
Date Value
2021-12-31 -71.33%
2020-12-31 -57.01%
2019-12-31 -77.04%
2018-12-31 -33.39%
2017-12-31 48.68%
2016-12-31 -59.23%
2015-12-31 18.53%
2014-12-31 -57.85%
2013-12-31 -6100.00%
2012-12-31 -392.31%
CNCE ROE (Return on Equity) - Peers Comparison